{"url_path":"/sec/sgmt/8-k/2026-06-12/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-12","source_url":"https://www.sec.gov/Archives/edgar/data/1400118/0001104659-26-073431-index.html","accession_number":"0001104659-26-073431","cik":"0001400118","ticker":"SGMT","issuer_name":"Sagimet Biosciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1400118/0001104659-26-073431-index.html","primary_entity_key":"0001400118","primary_entity_name":"Sagimet Biosciences Inc."},"word_count":85,"has_tables":true,"body_markdown":"**Item 5.02**\n**Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\n \n\nOn June 12, 2026, Tim Walbert, a member of the Board of Directors\n(the “Board”) of Sagimet Biosciences Inc. (the “Company”), tendered his resignation from the Board, effective\nas of June 12, 2026. Mr. Walbert’s resignation from the Board was due to other commitments and not the result of any disagreement\nwith the Company on any matter relating to the Company’s operations, policies or practices."}